Lucijanić, M., Krečak, I., Soric, E., Sabljić, A., Galusic, D., Holik, H. ... Kušec, R. (2022). Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. Leukemia Research, 119.. doi: 10.1016/j.leukres.2022.106905

Lucijanić, Marko, et al. "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis." Leukemia Research, vol. 119, 2022. https://doi.org/10.1016/j.leukres.2022.106905

Lucijanić, Marko, Ivan Krečak, Ena Soric, Anica Sabljić, Davor Galusic, Hrvoje Holik, Vlatka Periša, Martina Morić Perić, Ivan Zekanović and Rajko Kušec. "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis." Leukemia Research 119 (2022). https://doi.org/10.1016/j.leukres.2022.106905

Lucijanić, M., et al. (2022) 'Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis', Leukemia Research, 119. doi: 10.1016/j.leukres.2022.106905

Lucijanić M, Krečak I, Soric E, Sabljić A, Galusic D, Holik H, and sur.. Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. Leukemia Research [Internet]. 2022 August [cited 2024 July 30];119. doi: 10.1016/j.leukres.2022.106905

M. Lucijanić, et al., "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis", Leukemia Research, vol. 119, August 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:839295. [Accessed: 30 July 2024]